Miguel Bigotte Vieira

24PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Sport and exercise nutritionPharmacogenomicsCheminformatics and quantitative structure-activity relationshipsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 26, 2026
The Potential Role of SGLT2 Inhibitors in Cushing's Disease.

|Apr 24, 2026
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

|Dec 19, 2025
Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.

João Sérgio Neves, Ana Rita Leite, Catarina Vale

|Dec 10, 2025
Aldosterone antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor monotherapy: An updated meta-analysis.

Luís Mendonça, João Sérgio Neves, Francisco Vasques-Nóvoa

|Sep 08, 2025
Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLD.

Marta Borges-Canha, Javier Centelles-Lodeiro, Ana Rita Leite

|Sep 02, 2025
Albuminuria Is the Key Driver of Kidney Benefit with Aldosterone Receptor Antagonists in Type 2 Diabetes.

João Pedro Ferreira, Luís Mendonça, Pedro Marques

Pageof 4

Frequent Collaborators

7 joint publications

João Pedro Ferreira

6 joint publications

Ana Rita Leite

4 joint publications

Davide Carvalho

4 joint publications

Marta Borges-Canha